CO6551683A2 - Tratamiento para trastornos gastrointestinales - Google Patents
Tratamiento para trastornos gastrointestinalesInfo
- Publication number
- CO6551683A2 CO6551683A2 CO12081055A CO12081055A CO6551683A2 CO 6551683 A2 CO6551683 A2 CO 6551683A2 CO 12081055 A CO12081055 A CO 12081055A CO 12081055 A CO12081055 A CO 12081055A CO 6551683 A2 CO6551683 A2 CO 6551683A2
- Authority
- CO
- Colombia
- Prior art keywords
- gastrointestinal disorders
- treatment
- present
- pharmaceutical compositions
- provides
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25926409P | 2009-11-09 | 2009-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6551683A2 true CO6551683A2 (es) | 2012-10-31 |
Family
ID=43503086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO12081055A CO6551683A2 (es) | 2009-11-09 | 2012-05-16 | Tratamiento para trastornos gastrointestinales |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US8507447B2 (enExample) |
| EP (1) | EP2499154B1 (enExample) |
| JP (1) | JP5913115B2 (enExample) |
| KR (1) | KR20120115495A (enExample) |
| CN (1) | CN102812038B (enExample) |
| AR (1) | AR078950A1 (enExample) |
| AU (1) | AU2010314866B2 (enExample) |
| BR (1) | BR112012011730A2 (enExample) |
| CA (1) | CA2779482A1 (enExample) |
| CL (1) | CL2012001186A1 (enExample) |
| CO (1) | CO6551683A2 (enExample) |
| CR (1) | CR20120303A (enExample) |
| EA (1) | EA022817B1 (enExample) |
| EC (1) | ECSP12011962A (enExample) |
| ES (1) | ES2620153T3 (enExample) |
| GE (1) | GEP20166435B (enExample) |
| IL (1) | IL219596A0 (enExample) |
| MX (2) | MX350046B (enExample) |
| NZ (1) | NZ599751A (enExample) |
| PH (1) | PH12012500916B1 (enExample) |
| SG (1) | SG10201407403UA (enExample) |
| TW (1) | TWI482626B (enExample) |
| UA (1) | UA114274C2 (enExample) |
| UY (2) | UY33017A (enExample) |
| WO (1) | WO2011057272A1 (enExample) |
| ZA (1) | ZA201203342B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| JP2012510518A (ja) * | 2008-12-02 | 2012-05-10 | アイロンウッド ファーマシューティカルズ，インコーポレーテッド | 体液貯留障害を処置するための方法および組成物 |
| MX350046B (es) * | 2009-11-09 | 2017-08-24 | Ironwood Pharmaceuticals Inc | Tratamientos para trastornos gastrointestinales. |
| KR20120103689A (ko) * | 2009-12-07 | 2012-09-19 | 아이언우드 파마슈티컬스, 인코포레이티드 | 위장 장애의 치료 |
| US9303066B2 (en) | 2011-05-11 | 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US20160213739A1 (en) * | 2011-05-11 | 2016-07-28 | Ironwood Pharmaceuticals, Inc | Treatments for disorders using guanylate cyclase c agonists |
| WO2012155101A1 (en) * | 2011-05-11 | 2012-11-15 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| WO2012170804A1 (en) * | 2011-06-08 | 2012-12-13 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US9527887B2 (en) | 2011-06-08 | 2016-12-27 | Ironwood Pharmaceutical, Inc. | Treatments for gastrointestinal disorders |
| CN104053449B (zh) * | 2011-08-17 | 2016-12-07 | 硬木药品公司 | 胃肠疾患的治疗 |
| JP2016521249A (ja) * | 2012-07-12 | 2016-07-21 | フォレスト ラボラトリーズ ホールディングス リミテッド | リナクロチド組成物 |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| CA2920856C (en) | 2013-08-09 | 2026-03-03 | Ardelyx, Inc. | Ph modulating compounds for inhibiting gastrointestinal phosphate uptake |
| JP2016534043A (ja) * | 2013-10-09 | 2016-11-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 炎症促進性サイトカインのダウンレギュレーションに有用なグアニル酸シクラーゼのアゴニスト |
| WO2016015055A1 (en) * | 2014-07-25 | 2016-01-28 | Ironwood Pharmaceuticals, Inc. | Colon cleansing compositions |
| JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス， インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB290795A (en) | 1927-04-08 | 1928-05-24 | British Colour Printing Compan | Improvements in or relating to advertising or display devices |
| WO1995011694A1 (en) | 1993-10-26 | 1995-05-04 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| US5601990A (en) | 1994-09-13 | 1997-02-11 | Thomas Jefferson University | Methods of diagnosing colorectal tumors and metastasis thereof |
| US5879656A (en) | 1993-10-26 | 1999-03-09 | Thomas Jefferson University | Methods of treating metastatic colorectal cancer with ST receptor binding compounds |
| US5962220A (en) | 1993-10-26 | 1999-10-05 | Thomas Jefferson University | Compositions that specifically bind to colorectal cells and methods of using the same |
| US5518888A (en) | 1993-10-26 | 1996-05-21 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
| CH689139A5 (de) | 1995-04-03 | 1998-10-30 | Cerbios Pharma Sa | Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung. |
| US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| AU2001256315A1 (en) * | 2000-04-22 | 2001-11-07 | Ipf Pharmaceuticals Gmbh | Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type 2 |
| BR122018074353B8 (pt) | 2003-01-28 | 2023-05-02 | Ironwood Pharmaceuticals Inc | composição farmacêutica, polipeptídeo e métodos para a produção dos mesmos |
| US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7772188B2 (en) * | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP1940441A4 (en) * | 2005-08-19 | 2010-01-27 | Ironwood Pharmaceuticals Inc | COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS |
| WO2008151257A2 (en) * | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| RS60101B1 (sr) | 2008-08-15 | 2020-05-29 | Ironwood Pharmaceuticals Inc | Formulacije koje sadrže linaklotid za oralnu primenu |
| WO2010027405A2 (en) | 2008-09-04 | 2010-03-11 | Ironwood Pharmaceuticals, Inc. | Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration |
| MX350046B (es) * | 2009-11-09 | 2017-08-24 | Ironwood Pharmaceuticals Inc | Tratamientos para trastornos gastrointestinales. |
| EP2605786A4 (en) | 2010-06-09 | 2014-03-12 | Combimab Inc | THERAPEUTIC PEPTIDES |
-
2010
- 2010-11-09 MX MX2014016035A patent/MX350046B/es unknown
- 2010-11-09 US US12/942,887 patent/US8507447B2/en active Active
- 2010-11-09 BR BR112012011730A patent/BR112012011730A2/pt not_active IP Right Cessation
- 2010-11-09 US US13/508,843 patent/US20140179607A9/en not_active Abandoned
- 2010-11-09 JP JP2012538087A patent/JP5913115B2/ja not_active Expired - Fee Related
- 2010-11-09 KR KR1020127014811A patent/KR20120115495A/ko not_active Abandoned
- 2010-11-09 NZ NZ599751A patent/NZ599751A/en not_active IP Right Cessation
- 2010-11-09 TW TW099138547A patent/TWI482626B/zh not_active IP Right Cessation
- 2010-11-09 CA CA2779482A patent/CA2779482A1/en not_active Abandoned
- 2010-11-09 CN CN201080060997.XA patent/CN102812038B/zh not_active Expired - Fee Related
- 2010-11-09 PH PH1/2012/500916A patent/PH12012500916B1/en unknown
- 2010-11-09 AU AU2010314866A patent/AU2010314866B2/en not_active Ceased
- 2010-11-09 GE GEAP201012738A patent/GEP20166435B/en unknown
- 2010-11-09 EA EA201290322A patent/EA022817B1/ru not_active IP Right Cessation
- 2010-11-09 MX MX2012005368A patent/MX2012005368A/es active IP Right Grant
- 2010-11-09 WO PCT/US2010/056042 patent/WO2011057272A1/en not_active Ceased
- 2010-11-09 UY UY0001033017A patent/UY33017A/es not_active Application Discontinuation
- 2010-11-09 UY UY0001033018A patent/UY33018A/es not_active Application Discontinuation
- 2010-11-09 AR ARP100104153A patent/AR078950A1/es unknown
- 2010-11-09 ES ES10782095.3T patent/ES2620153T3/es active Active
- 2010-11-09 UA UAA201206987A patent/UA114274C2/uk unknown
- 2010-11-09 SG SG10201407403UA patent/SG10201407403UA/en unknown
- 2010-11-09 EP EP10782095.3A patent/EP2499154B1/en active Active
-
2012
- 2012-05-03 IL IL219596A patent/IL219596A0/en unknown
- 2012-05-07 ZA ZA2012/03342A patent/ZA201203342B/en unknown
- 2012-05-07 CL CL2012001186A patent/CL2012001186A1/es unknown
- 2012-05-16 CO CO12081055A patent/CO6551683A2/es active IP Right Grant
- 2012-06-06 CR CR20120303A patent/CR20120303A/es unknown
- 2012-06-08 EC ECSP12011962 patent/ECSP12011962A/es unknown
-
2013
- 2013-03-14 US US13/830,656 patent/US8946158B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP12011962A (es) | Tratamientos para trastornos gastrointestinales | |
| CY1124311T1 (el) | Παρεμποδιστες dna-pk | |
| EA033374B1 (ru) | Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения | |
| CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
| EA201591166A1 (ru) | Ингибиторы аутотаксина | |
| PH12013502261A1 (en) | Partially saturated tricyclic compounds and methods of making and using same | |
| HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| EA201390803A1 (ru) | Ингибиторы бромодомена и их применение | |
| EA201170356A1 (ru) | Полиморфные и аморфные формы лакозамида и аморфные композиции | |
| CR20120202A (es) | Métodos y composiciones para tratar cáncer | |
| MX376008B (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
| EA201590165A1 (ru) | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения | |
| EA201691079A1 (ru) | Комбинированная терапия для лечения онкологического заболевания | |
| RU2018145985A (ru) | Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений | |
| MX343687B (es) | Compuestos sulfonamida tricíclica y métodos para su fabricación y uso. | |
| EA201590590A1 (ru) | Модуляторы рецептора андрогенов и их применение | |
| EA201390506A1 (ru) | Полипептиды, которые связывают компонент с5 комплемента человека | |
| MX2014008705A (es) | Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos. | |
| MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
| UY34116A (es) | El anticuerpo neutralizador del receptor de prolactina mat3 y su uso terapéutico | |
| MX356755B (es) | Compuestos de tipo fumagilol y metodos para su elaboración y uso. | |
| MX2022013283A (es) | Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales. | |
| CO7151509A2 (es) | Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de bace1 | |
| MX2015005732A (es) | Compuestos tricíclicos y métodos para hacer y utilizar los mismos. | |
| CY1116234T1 (el) | Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted |